ViiV Healthcare
Last update: August 19, 2020
Pharmaceuticals
United Kingdom (UK)
Its 21 main executives
Create an alert
to follow the executive moves at ViiV Healthcare.
Most searched biographies at ViiV Healthcare
- Deborah Waterhouse, Chief Executive Officer
- Sabine Luik, Director
- David Redfern, Chairman of the Board
Click on an executive to view his biography >
Latest M&A news in Pharmaceuticals.
Bristol-Myers Squibb has announced the acquisition of MyoKardia (posted on Oct 6, 2020).
DelMar Pharmaceuticals has announced the acquisition of Kintara Therapeutics (posted on Aug 19, 2020).
Elanco has acquired Bayer Animal Health (posted on Aug 5, 2020).
Other contacts in the Pharmaceuticals industry
Latest news about ViiV Healthcare
ViiV Healthcare announces new strategic alliance to enable greater access to antiretroviral medicines in Brazil
ViiV Healthcare announces superior efficacy of investigational, long-acting injectable formulation of cabotegravir dosed every two months over daily oral PrEP
ViiV Healthcare presents positive data from first-ever implementation research study on how best to integrate a investigational once-monthly injectable HIV treatment in US healthcare practices
ViiV Healthcare shares new data from Positive Perspectives, Wave 2 study, confirming a more holistic approach to HIV care can improve quality of life
ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults with few treatment options available
ViiV Healthcare on Wikipedia, Google News & Yahoo Finance
ViiV Healthcare on LinkedIn, Twitter & YouTube
ViiV Healthcare has 2,018 competitors including Sun Pharma (India), Johnson & Johnson (United States (USA)) and Roche (Switzerland). ViiV Healthcare is owned by GSK.
Contact by email its executives including David Redfern 
Call ViiV Healthcare at +44 792....
